FDA (CDER)
GUIDANCE DRAFT
M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol
Published: 6/6/2025Detected: 3/20/2026
Summary preview
Defines a draft M11 technical specification for clinical electronic structured harmonised protocol representations, which may change how clinical trial protocols are authored, structured, and exchanged for regulatory…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountclinical
safety
labeling
quality
manufacturing
#clinical electronic protocol
#structured protocol
#harmonised representation
#regulatory submissions
#FDA CDER
Official Source Document Source Verified
Access the original document directly from FDA CDER.
More from FDA (CDER)
- E2B(R3) Electronic Transmission of Individual Case Safety Reports Implementation Guide — Data Elements and Message Specification; and Appendix to the Implementation Guide — Backwards and Forwards Compatibility10/1/2026
- Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates: Guidance for Industry9/8/2026
- Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling9/2/2026
- Evaluation of Therapeutic Equivalence8/21/2026
- Determining Whether to Submit an ANDA or a 505(b)(2) Application8/17/2026